Sean Zheng
Director/Board Member at NOVABAY PHARMACEUTICALS, INC.
Net worth: 66 $ as of 29/04/2024
Profile
Sean Zheng is currently the Chief Executive Officer at Q3 Medical Devices Shanghai Co. Ltd.
and also serves as the Director at NovaBay Pharmaceuticals, Inc. starting from 2022.
Previously, he worked as a Director at Dingtian Asset Management Co., Ltd.
from 2007 to 2011 and as a Managing Director at Boill Fund Management Hk Co. Ltd.
He holds an MBA from The University of New South Wales (2002) and China Europe International Business School (2010) and an undergraduate degree from Renmin University of China (1992).
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
31/03/2024 | 858 ( 0.00% ) | 66 $ | 29/04/2024 |
Sean Zheng active positions
Companies | Position | Start |
---|---|---|
NOVABAY PHARMACEUTICALS, INC. | Director/Board Member | 26/01/2022 |
Q3 Medical Devices Shanghai Co. Ltd. | Chief Executive Officer | - |
Former positions of Sean Zheng
Companies | Position | End |
---|---|---|
Dingtian Asset Management Co., Ltd. | Director/Board Member | 31/12/2010 |
Boill Fund Management Hk Co. Ltd. | Chief Executive Officer | - |
Training of Sean Zheng
The University of New South Wales | Masters Business Admin |
China Europe International Business School | Masters Business Admin |
Renmin University of China | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
NOVABAY PHARMACEUTICALS, INC. | Health Technology |
Private companies | 3 |
---|---|
Dingtian Asset Management Co., Ltd. | |
Q3 Medical Devices Shanghai Co. Ltd. | |
Boill Fund Management Hk Co. Ltd. |
- Stock Market
- Insiders
- Sean Zheng